Matthias Schlensak
Overview
Explore the profile of Matthias Schlensak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
724
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sarabhai T, Kahl S, Gancheva S, Mastrototaro L, Dewidar B, Pesta D, et al.
Metabolism
. 2024 Dec;
164:156107.
PMID: 39721563
No abstract available.
2.
Kahl S, Strassburger K, Pacini G, Trinks N, Pafili K, Mastrototaro L, et al.
J Hepatol
. 2024 Sep;
82(3):417-426.
PMID: 39218222
Background & Aims: Hepatic mitochondrial respiration is higher in steatosis, but lower in overt type 2 diabetes. We hypothesized that hepatic oxidative phosphorylation (OXPHOS) capacity increases with a greater degree...
3.
Kovac L, Gancheva S, Jahnert M, Sehgal R, Mastrototaro L, Schlensak M, et al.
Diabetes Metab
. 2024 Jul;
50(5):101561.
PMID: 38977261
Aim: Bariatric surgery is highly effective for the treatment of obesity in individuals without (OB) and in those with type 2 diabetes (T2D). However, whether bariatric surgery triggers similar or...
4.
Sarabhai T, Kahl S, Gancheva S, Mastrototaro L, Dewidar B, Pesta D, et al.
Metabolism
. 2023 Dec;
151:155762.
PMID: 38122893
Background: Obesity and type 2 diabetes frequently have metabolic dysfunction-associated steatotic liver disease (MASLD) including steatohepatitis (MASH). In obesity, the liver may adapt its oxidative capacity, but the role of...
5.
Gancheva S, Kahl S, Herder C, Strassburger K, Sarabhai T, Pafili K, et al.
Int J Obes (Lond)
. 2023 Mar;
47(6):505-511.
PMID: 36959287
Aims: Body weight loss improves insulin resistance and growth hormone secretion in obesity, which may be regulated by leptin according to preclinical studies. How changes in leptin, lipids and insulin...
6.
Pafili K, Kahl S, Mastrototaro L, Strassburger K, Pesta D, Herder C, et al.
J Hepatol
. 2022 Aug;
77(6):1504-1514.
PMID: 35988689
Background & Aims: Adipose tissue dysfunction is involved in the development of insulin resistance and is responsible for excessive lipid delivery to other organs such as the liver. We tested...
7.
Gancheva S, Ouni M, Jelenik T, Koliaki C, Szendroedi J, Toledo F, et al.
Nat Commun
. 2022 Jun;
13(1):3353.
PMID: 35688803
No abstract available.
8.
Gancheva S, Kahl S, Pesta D, Mastrototaro L, Dewidar B, Strassburger K, et al.
Diabetes Care
. 2022 Feb;
45(4):928-937.
PMID: 35113139
Objective: Individuals with type 2 diabetes are at higher risk of progression of nonalcoholic fatty liver (steatosis) to steatohepatitis (NASH), fibrosis, and cirrhosis. The hepatic metabolism of obese individuals adapts...
9.
Apostolopoulou M, Gordillo R, Gancheva S, Strassburger K, Herder C, Esposito I, et al.
BMJ Open Diabetes Res Care
. 2020 Nov;
8(2).
PMID: 33219119
Introduction: Sphingolipid accumulation has been linked to obesity, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). A recent study showed that depletion of dihydroceramide desaturase-1 (DES-1) in adipose and/or...
10.
Gancheva S, Ouni M, Jelenik T, Koliaki C, Szendroedi J, Toledo F, et al.
Nat Commun
. 2019 Sep;
10(1):4179.
PMID: 31519890
The mechanisms underlying improved insulin sensitivity after surgically-induced weight loss are still unclear. We monitored skeletal muscle metabolism in obese individuals before and over 52 weeks after metabolic surgery. Initial...